Literature DB >> 26214620

Current insights into the association of Nestin with tumor angiogenesis.

Andrea Onisim1, Andrei Achimas-Cadariu, Catalin Vlad, Paul Kubelac, Patriciu Achimas-Cadariu.   

Abstract

Tumor angiogenesis is regarded as a hallmark of cancer and provides an important target for therapy. Nestin is an intermediate filament protein (IF) originally recognized as a neural stem cell marker. Development and progression of cancer requires sustained angiogenesis, dependent on the proliferation and migration of endothelial cells which seem to be better portrayed by nestin expression in various malignancies such as central nervous system, gastro-intestinal cancers, malignant melanoma, lung, prostate or breast cancer. The purpose of the present review was to emphasize the insights into nestin expression in relation to tumor angiogenesis in different types of cancer. Current evidence suggests that nestin positivity in tumor cells reflects stem-like properties of those cells. Whether or not expressed in both tumor and endothelial cells, nestin overexpression might reflect the extent of angiogenesis and function as a molecular anti-angiogenic target for cancer.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26214620

Source DB:  PubMed          Journal:  J BUON        ISSN: 1107-0625            Impact factor:   2.533


  10 in total

1.  Histopathological vascular investigation of the peritumoral brain zone of glioblastomas.

Authors:  Ryota Tamura; Kentaro Ohara; Hikaru Sasaki; Yukina Morimoto; Kazunari Yoshida; Masahiro Toda
Journal:  J Neurooncol       Date:  2017-11-29       Impact factor: 4.130

2.  Nestin expression in breast cancer: association with prognosis and subtype on 3641 cases with long-term follow-up.

Authors:  Karama Asleh; Jennifer R Won; Dongxia Gao; K David Voduc; Torsten O Nielsen
Journal:  Breast Cancer Res Treat       Date:  2017-11-20       Impact factor: 4.872

3.  Nestin expression on tumour vessels and tumour-infiltrating macrophages define a poor prognosis subgroup of pt1 clear cell renal cell carcinoma.

Authors:  Jérôme Cros; Emilie Sbidian; Katia Posseme; Alexia Letierce; Catherine Guettier; Gérard Benoît; Sophie Ferlicot
Journal:  Virchows Arch       Date:  2016-06-17       Impact factor: 4.064

4.  Implications of dietary ω-3 and ω-6 polyunsaturated fatty acids in breast cancer.

Authors:  Oana Zanoaga; Ancuta Jurj; Lajos Raduly; Roxana Cojocneanu-Petric; Enrique Fuentes-Mattei; Oscar Wu; Cornelia Braicu; Claudia Diana Gherman; Ioana Berindan-Neagoe
Journal:  Exp Ther Med       Date:  2017-11-16       Impact factor: 2.447

Review 5.  Fertility preservation in Hodgkin's lymphoma patients that undergo targeted molecular therapies: an important step forward from the chemotherapy era.

Authors:  Alexandra Traila; Patriciu Achimas-Cadariu; Delia Dima; Romeo Micu
Journal:  Cancer Manag Res       Date:  2018-06-13       Impact factor: 3.989

6.  miRNA expression profiling in formalin-fixed paraffin-embedded endometriosis and ovarian cancer samples.

Authors:  Ovidiu-Leonard Braicu; Liviuta Budisan; Rares Buiga; Ancuta Jurj; Patriciu Achimas-Cadariu; Laura Ancuta Pop; Cornelia Braicu; Alexandru Irimie; Ioana Berindan-Neagoe
Journal:  Onco Targets Ther       Date:  2017-08-28       Impact factor: 4.147

7.  Expression of Nestin associates with BRCA1 mutations, a basal-like phenotype and aggressive breast cancer.

Authors:  Kristi Krüger; Elisabeth Wik; Gøril Knutsvik; Hawa Nalwoga; Tor A Klingen; Jarle B Arnes; Ying Chen; Monica Mannelqvist; Konstantina Dimitrakopoulou; Ingunn M Stefansson; Even Birkeland; Turid Aas; Nicholas P Tobin; Inge Jonassen; Jonas Bergh; William D Foulkes; Lars A Akslen
Journal:  Sci Rep       Date:  2017-04-24       Impact factor: 4.379

8.  Nestin expression involves invasiveness of esophageal carcinoma and its downregulation enhances paclitaxel sensitivity to esophageal carcinoma cell apoptosis.

Authors:  Jinghang Zhang; Jiateng Zhong; Jian Yu; Jinsong Li; Wenyu Di; Ping Lu; Xiaoyu Yang; Weixing Zhao; Xianwei Wang; Wei Su
Journal:  Oncotarget       Date:  2017-05-10

9.  Clinicopathological and prognostic significance of nestin expression in patients with breast cancer: a systematic review and meta-analysis.

Authors:  Xinyi Zhang; Changsheng Xing; Wenting Guan; Lang Chen; Kai Guo; Anze Yu; Kai Xie
Journal:  Cancer Cell Int       Date:  2020-05-14       Impact factor: 5.722

Review 10.  Nestin-Expressing Cells in the Lung: The Bad and the Good Parts.

Authors:  Gilberto Jaramillo-Rangel; María-de-Lourdes Chávez-Briones; Adriana Ancer-Arellano; Marta Ortega-Martínez
Journal:  Cells       Date:  2021-12-04       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.